2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow EMS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia. WAS123, Aripiprazole (Fixed dose) - Schizophenia Disorder | Phase 2 | Completed | EMS | 121 | 2022-05-10 | 2026-09-25 |
| Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification SATURNO II association, Vigadexa® - Ocular Inflammation, Cataract | Phase 2 | Completed | EMS | 118 | 2020-02-27 | 2022-03-07 |
Cataract (1) · Schizophrenia (1)
Aripiprazole (1) · Moxifloxacin (1)
Brazil (2)
Cassiano Berto (1)